학술논문

Phase III study results of Lomefloxaciin (NY-198) otic solution for the treatment of chronic purulent otitis media and its acute exacerbations / 慢性化膿性中耳炎および慢性化膿性中耳炎急性増悪症に対するLomefloxacin (NY-198) 耳用液の臨床第III相比較試験成績
Document Type
Journal Article
Author
Akihiko TAKASUAkio SUZUKIAkira TONAIGinichiro ICHIKAWAGoro MOGIHaruji KINOSHITAHideyo ASAIHideyuki KAWAUCHIHirofumi MATSUYAMAHirokazu KAWANOHiroshi WATANABEHitoshi OGINOHitoshi SAITOIchiho MORIBEIsao TAKIMOTOJun HONDOJunichi BUNDOKatsuhiro HIRAKAWAKazuaki OGAWAKazuhiko GOTOKazuhiko TAKEUCHIKen ARIKIKiichi SATOKiyo KANOKoichi DEGUCHIKoichi KITAKoichi YAMASHITAKoji YAJINKotaro UKAIKozo FUKAMIMakoto SHIRANEMasao NAITOMasao YASUDAMasaru OYAMAMikiko TAKAYAMAMikio YAGISAWAMinako YAMAMOTOMitsuhiro SANOMitsuru FURUKAWAMitsuyoshi NAKASHIMANagahiro SoNobuo TAKASUKANoriko OKADARyozo UMEDASatoaki HojoShigenobu IWATAShigeru INAFUKUShinji KATOShinjiro ONISHIShozo KAWAMURAShubun TAKEBAYASHIShunkich BABASugata TAKAHASHITadao NISHIMURATakashi KAWAITakatsugu ITABASHITakehiro KOBAYASHITakehisa SAITOTakeshi MARUOTamotsu MORIMITSUTatsuya TAKIGUCHITeruhisa NOIRITetsuji HORITetsuo ISHIITetsuya SHIMAToru KITAGAKIToru MATSUNAGAToshitada SAKAIToshiyuki MIYOSHITsuneharu HIROTAYasuo HARADAYasuo SAKAKURAYayoi SATOYoriko ITOYuichi NAKANOYuko NINOMIYAYutaka SAKAMOTO三好 敏之中島 光好中野 雄一丸尾 猛二宮 優子伊藤 依子佐藤 喜一佐藤 弥生佐野 光仁八木澤 幹夫内藤 雅夫出口 浩一分藤 準一加藤 眞二北垣 徹北條 郷明原田 康夫古川 仭坂倉 康夫坂本 裕堀 哲二夜陣 紘治大山 勝大西 信治郎安田 誠夫宗 永浩小川 和明小林 武弘山下 公一山本 美奈子岡田 能理子岩田 重信島 哲也川内 秀之市川 銀一郎平川 勝洋廣田 常治後藤 和彦斎藤 武久有木 健木下 治二本堂 潤東内 朗松山 博文松永 亨板橋 隆嗣梅田 良三森満 保森部 一穂河合 峯河村 正三河野 浩万浅井 英世深水 浩三渡辺 洋瀧口 哲也瀧本 勲狩野 秀代白根 誠石井 哲夫稲福 繁竹内 万彦竹林 脩文紀太 康一茂木 五郎荻野 仁西村 忠郎酒井 利忠野入 輝久鈴木 昭男馬場 駿吉高山 幹子高橋 姿高須 昭彦高須賀 信夫鵜飼 幸太郎齋藤 等
Source
耳鼻と臨床 / jibi to rinsho. 1991, 37(1):78
Subject
Lomefloxacin
NY-198
化膿性中耳炎
比較試験
耳用液
Language
Japanese
ISSN
0447-7227
2185-1034
Abstract
The efficacy, s afety and utility of lomefloxacin (NY-198) otic solution in chronic suppurative otitis media were evaluated by a well-controllecd omparative study using cefmenoxime (CMX) otic solution as a control.(1) Clinical effect: Whether based on the doctor's evaluation or the committee evaluation, no significandt difference was found between the NY-198 group and the CMXg roup. However, according to the doctor's evaluation, the NY-198 group tended to be superior in moderate cases.(2) Bacteriological effect: The NY-198 group tended to be superior in the elimination (%) of P. aeruginosa and was significantly more effective against gram-negative bacteria as a whole.(3) Side effects:Whereas side effects developed in 2 cases (2.0%) in the CMX group, no side effects were found in the NY-198 group.(4) Utility: The NY-198 group tended to be superior. Based on the above results, it was concluded that NY-198 otic solution would be a highly effective, safe and useful topical therapy for chronic suppurative otitis media.